Phase 1 Pharmacokinetic Study of Tapentadol Prolonged-Release 250 Milligram (mg) Formulation in Healthy Participants
Condition(s):HealthyLast Updated:June 13, 2013Completed
Hide Studies Not Open or Pending
Condition(s):HealthyLast Updated:June 13, 2013Completed
Condition(s):Chronic Pain; OsteoarthritisLast Updated:October 18, 2019Terminated
Condition(s):Lower Limb FractureLast Updated:August 21, 2023Completed
Condition(s):Chronic Pain; OsteoarthritisLast Updated:October 21, 2019Completed
Condition(s):Pain; Chronic Pain; Low Back Pain; Neuropathic Pain; Nociceptive PainLast Updated:January 9, 2019Terminated
Condition(s):Moderate to Severe Acute Postoperative PainLast Updated:January 29, 2018Terminated
Condition(s):Pain; CancerLast Updated:July 29, 2013Completed
Condition(s):Total Knee Replacement; Post-operative Pain; Chronic PainLast Updated:February 22, 2024Recruiting
Condition(s):Chronic Pain; Low Back PainLast Updated:January 15, 2019Completed
Condition(s):Postoperative Pain; Surgery; Pain, Postoperative; Pain, Acute; Pain, Chronic; Pain, Procedural; Pain, Neuropathic; AnalgesiaLast Updated:February 8, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.